Fresenius admits strong finish to 2013 needed to strike target
This article was originally published in Clinica
Executive Summary
Fresenius Medical Care will need a “very strong fourth quarter” to hit its guidance for 2013, admitted CEO Rice Powell as the firm reported third-quarter results. The company is anticipating full-year revenues of over $14.6bn, representing 6% year-on-year growth, and net income of $1.1-1.15bn, which is now expected to come in at the low end of this range.